We have found 46587 results matching your criteria.
Please wait while we search...
  1. 1.
    General Material Information
  2. 2.
    PhysChem Properties
  3. 3.
    Occurrences
  4. 4.
    Organoleptic Properties
  5. 5.
    Suppliers
  6. 6.
    Potential Uses
  7. 7.
    Regulatory & Documentation
  8. 8.
    Safety Information
  9. 9.
    Other Information
  10. 10.
    Blenders & Components
  11. 11.
    Literature & References

passiflora incarnata flower solid extract

General Material Information

Preferred name passiflora incarnata flower solid extract
Trivial Name passiflora incarnata l. flower extract
Short Description extract of the flowers of the passion flower, passiflora incarnata l., passifloraceae
CAS Number 8057-62-3
CAS Number 72968-47-9
ECHA Number 277-142-7
FDA UNII Search
FDA Mainterm 8057-62-3 ; PASSION FLOWER EXTRACT
Synonyms
  • extract of the flowers of the passion flower, passiflora incarnata l., passifloraceae
  • granadilla incarnata flower solid extract
  • passiflora edulis var. keriiflower flower solid extract
  • passiflora incarnata var. integriloba flower solid extract
  • passiflora kerii flower solid extract
  • passion flower extract solid
  • passionflower extract solid

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

passiflora incarnata l. flower extract
Pubchem (sid):135299400
passiflora incarnata l. flower extract
Pubchem (sid):135335921
Publications by PubMed
The efficacy of passiflora incarnata linnaeus in reducing dental anxiety in patients undergoing periodontal treatment.
Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats.
Male flowers are better fathers than hermaphroditic flowers in andromonoecious Passiflora incarnata.
Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models.
Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice.
Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice.
The effects of chrysin, a Passiflora incarnata extract, on natural killer cell activity in male Sprague-Dawley rats undergoing abdominal surgery.
An evidence-based systematic review of passion flower (Passiflora incarnata L.) by the Natural Standard Research Collaboration.
Risks and benefits of commonly used herbal medicines in Mexico.
Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors.
[Passion Flower (Passiflora incarnata L.)--a reliable herbal sedative].
Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse.
[Nature medicine as intoxicant].

Other Information

FDA Substances Added to Food (formerly EAFUS):View
FDA Listing of Food Additive Status:View
Wikipedia:View

PhysChem Properties

Material listed in food chemical codex No

Organoleptic Properties

Flavor Type: Fruity
fruity, molasses, malty, beer, earthy, petal, herbal
General comment Fruity molasses malty beer earthy petal herbal

Occurrences

Safety Information

Safety information

Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
oral-rat LD50 > 15000 mg/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Kiso to Rinsho. Clinical Report. Vol. 15, Pg. 3393, 1981.

intraperitoneal-rat LD50 3510 mg/kg
Drugs in Japan Vol. 6, Pg. APP-15, 1982.

oral-mouse LD50 > 15000 mg/kg
SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Kiso to Rinsho. Clinical Report. Vol. 15, Pg. 3393, 1981.

intraperitoneal-mouse LD50 3140 mg/kg
Drugs in Japan Vol. 6, Pg. APP-15, 1982.

Dermal Toxicity:
subcutaneous-rat LD50 > 10000 mg/kg
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BLOOD: CHANGES IN SPLEEN KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION
Kiso to Rinsho. Clinical Report. Vol. 15, Pg. 3393, 1981.

subcutaneous-mouse LD50 8300 mg/kg
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Kiso to Rinsho. Clinical Report. Vol. 15, Pg. 3393, 1981.

Inhalation Toxicity:
Not determined

Safety in use information

Category:
cosmetic and flavor agents
Recommendation for passiflora incarnata flower solid extract usage levels up to:
not for fragrance use.

Safety references

ClinicalTrials.gov:search
Daily Med:search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
National Institute of Allergy and Infectious Diseases:Data
passiflora incarnata l. flower extract
Chemidplus:0008057623
passiflora incarnata l. flower extract
Chemidplus:0072968479